OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
DEXP358

Dexxos Participacoes SA

Commodity ChemicalsVerified

Dexxos maintains a strong liquidity position, with a current ratio of 3.65 and cash and equivalents amounting to BRL 390.9 million, which represents 24.2% of total assets. The company's debt-to-equity ratio is 0.29, indicating a conservative capital structure with limited leverage. Free cash flow for the period was BRL 20.8 million, while capital expenditures were BRL -59.4 million, suggesting a focus on asset optimization rather than expansion. Profitability metrics show a return on equity (ROE) of 14.34% and a return on assets (ROA) of 8.9%, both exceeding the typical thresholds for the Commodity Chemicals industry. Gross profit of BRL 338.3 million and operating income of BRL 218.7 million reflect a healthy margin structure, with net income of BRL 143.7 million translating to a net margin of 6.7%. Geographically, Dexxos is concentrated in Brazil, with no disclosed international revenue segments. The company operates a single business segment focused on commodity chemicals, with no material diversification across product lines or geographic regions. Looking ahead, revenue is expected to remain stable, with no significant growth or contraction projected in the next fiscal year. The company's operating cash flow of BRL 224.8 million supports its current operations, and there are no immediate signs of financial distress or capital raising pressures. Risk factors include exposure to commodity price volatility and regulatory changes in the Brazilian chemical industry. However, the company's liquidity position and low debt levels mitigate near-term financial risk. No dilution risks were identified in recent filings, and the number of shares outstanding has remained unchanged. Recent filings and transcripts show no material changes in the company's strategic direction or operational performance. Analysts have assigned a mean price target of BRL 10.67, with a single "buy" recommendation and no "strong buy" or "hold" ratings, indicating cautious optimism.

30-day price · DEXP3+0.14 (+2.0%)
Low$6.94High$7.51Close$7.21As of15 May, 00:00 UTC
Profile
CompanyDexxos Participacoes SA
TickerDEXP3.SA
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Dexxos Participacoes SA is a Brazilian company engaged in the production and distribution of commodity chemicals, primarily serving industrial and consumer markets.

Classification. Dexxos is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

Dexxos maintains a strong liquidity position, with a current ratio of 3.65 and cash and equivalents amounting to BRL 390.9 million, which represents 24.2% of total assets. The company's debt-to-equity ratio is 0.29, indicating a conservative capital structure with limited leverage. Free cash flow for the period was BRL 20.8 million, while capital expenditures were BRL -59.4 million, suggesting a focus on asset optimization rather than expansion. Profitability metrics show a return on equity (ROE) of 14.34% and a return on assets (ROA) of 8.9%, both exceeding the typical thresholds for the Commodity Chemicals industry. Gross profit of BRL 338.3 million and operating income of BRL 218.7 million reflect a healthy margin structure, with net income of BRL 143.7 million translating to a net margin of 6.7%. Geographically, Dexxos is concentrated in Brazil, with no disclosed international revenue segments. The company operates a single business segment focused on commodity chemicals, with no material diversification across product lines or geographic regions. Looking ahead, revenue is expected to remain stable, with no significant growth or contraction projected in the next fiscal year. The company's operating cash flow of BRL 224.8 million supports its current operations, and there are no immediate signs of financial distress or capital raising pressures. Risk factors include exposure to commodity price volatility and regulatory changes in the Brazilian chemical industry. However, the company's liquidity position and low debt levels mitigate near-term financial risk. No dilution risks were identified in recent filings, and the number of shares outstanding has remained unchanged. Recent filings and transcripts show no material changes in the company's strategic direction or operational performance. Analysts have assigned a mean price target of BRL 10.67, with a single "buy" recommendation and no "strong buy" or "hold" ratings, indicating cautious optimism.
Key takeaways
  • Dexxos maintains a conservative capital structure with a low debt-to-equity ratio of 0.29 and strong liquidity.
  • The company's ROE of 14.34% and ROA of 8.9% indicate strong profitability relative to industry norms.
  • Revenue is concentrated in Brazil, with no international diversification disclosed.
  • Analysts project a stable outlook with a mean price target of BRL 10.67 and one "buy" recommendation.
  • No immediate liquidity or dilution risks are present, and capital expenditures are focused on asset optimization.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyBRL
Revenue$2.14B
Gross profit$338.3M
Operating income$218.7M
Net income$143.7M
R&D
SG&A
D&A
SBC
Operating cash flow$224.8M
CapEx-$59.4M
Free cash flow$20.8M
Total assets$1.61B
Total liabilities$611.8M
Total equity$1.00B
Cash & equivalents$390.9M
Long-term debt$292.8M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.00B
Net cash$98.1M
Current ratio3.6
Debt/Equity0.3
ROA8.9%
ROE14.3%
Cash conversion1.6%
CapEx/Revenue-2.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricDEXP3Activity
Op margin10.2%5.5% medp25 -0.0% · p75 10.8%above median
Net margin6.7%4.1% medp25 0.1% · p75 8.8%above median
Gross margin15.8%20.5% medp25 12.4% · p75 29.7%below median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-2.8%-6.2% medp25 -13.4% · p75 -2.6%above median
Debt / equity29.0%37.1% medp25 10.3% · p75 82.0%below median
Observations
IR observations
Mean price target10.67 BRL
Median price target10.67 BRL
High price target10.67 BRL
Low price target10.67 BRL
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Last actual revenue2,136,828,000 BRL
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-15 14:28 UTC#42ac2c72
Market quoteclose BRL 7.22 · shares 0.12B diluted
no public URL
2026-05-15 14:30 UTC#199ea8bc
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 18:31 UTCJob: 23a989c5